CLINICAL_TRIALS
trial_result
· 2018-11-05
Clinical Trial Update: Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)
Summary
Clinical trial update for Viviant 20mg under a regulatory post-marketing commitment plan; the study completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2018-11-05